Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW 3,960.00
+325.00 (8.94%)
Sep 11, 2024, 3:00 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 182.55 billion as of September 11, 2024. Its market cap has increased by 65.75% in one year.
Market Cap
182.55B
Enterprise Value
179.23B
Revenue
-340.00
Ranking
n/a
PE Ratio
n/a
Stock Price
3,960.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 182.55B, a decrease of -39.18%. That is a compound annual growth rate of -9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2024 | 182.55B | 149.69% |
| Dec 28, 2023 | 73.11B | -68.32% |
| Dec 29, 2022 | 230.80B | -17.53% |
| Dec 30, 2021 | 279.85B | 0.27% |
| Dec 30, 2020 | 279.09B | -12.04% |
| Dec 30, 2019 | 317.28B | 5.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition